Predictive Value of 68Ga-FAPI-04 PET/MR for Left Ventricular Remodeling in Patients with Acute Myocardial Infarction
Journal: Research Square
Year: 2022

Abstract Purpose To observe longitudinal changes of myocardial fibroblasts activation by 68 Ga-labeled fibroblast activation protein inhibitor ( 68 Ga-FAPI-04) PET/MR in patients with ST-segment elevated myocardial infarction (STEMI), and assess its predictive value for late left ventricular remodeling (LVR). Methods Forty-two patients with STEMI were included in the study. 68 Ga-FAPI-04 PET/MR was performed at baseline (5.1 ± 3.0 days) and at 12 months (12.0 ± 1.1 months) after STEMI. The exten